The global cefazolin sodium market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Cefazolin is a drug which is used to treat bacterial infection including skin, bones, joints, genital, respiratory tract, and urinary tract infection. It is also used after several surgeries to prevent the patients from getting an infection. The major factor for the market to grow is the increasing prevalence of infectious diseases globally. Additionally, this drug is also used for penicillin-allergic patients with heart conditions and will undergo dental or respiratory track operation to prevent them from developing heart valve infection. This is boosting the global cefazolin sodium market growth. However, side effects like diarrhea, loss of appetite among others are some of the restraining factor for the growth of global cefazolin sodium market.
Impact of COVID-19 Pandemic on Global Cefazolin sodium market
During the COVID-19 pandemic, there was a shortfall of raw materials globally. Mostly, the main raw materials for this drug are supplied by China. As lots of countries had imposed trade restrictions on the countries having high prevalence of COVID-19, thus had disrupted the supply chain network of raw materials. Due to this reason manufacturing of cefazolin sodium delayed. However, many countries used cefazolin drug along with other antibiotics in the intensive critical unit to treat COVID-19 patients. So, the demand for cefazolin drug was high in the market though the supply was limited.
Segmental Outlook
The global cefazolin sodium market is segmented based on the type and end-user. Based on the type, the market is segmented into antimicrobial drug, cephalosporins, and first generation cephalosporins. Amongst the type, antimicrobial drug cefazolin sodium market is anticipated to propel the growth of the market over the forecast period. Based on the end-user, the market is sub-segmented into adults and children. Amongst the end-user, the adults-treated cefazolin sodium market is anticipated to grow more during the forecast period. The above-mentioned segments can also be customized as per the requirements.
Global Cefazolin sodium market Share by Type, 2022 (%)
The Antimicrobial Drug Market is Anticipated to Hold a Prominent Share in the Global Cefazolin Sodium Market
The antimicrobial drug market is anticipated to hold the major share in the global cefazolin sodium market as this type of drug is used in the treatment of almost every type biological disease, from normal viral infection to the critical cancer treatment. However, the rising human resistance towards antimicrobial drugs is expected to restrain its further growth during the forecast period. According to the CDC, around 2 million people die every year globally due to the antimicrobial drug resistance. The researchers are now trying to develop new quality-assured antimicrobials drugs to treat carbapenem-resistant gram-negative bacterial infections. With these antimicrobial drugs, medical procedures such as surgery, cancer, chemotherapy, organ transplantation will become less risky from the infection point of view. Thus, such incidences are expected to fuel the market growth of this segment during the forecast period.
Adults are the Major End-User of Cefazolin Sodium Globally
Adults are the major end-user of cefazolin sodium globally. This is because adults are more prone of various infections as their age develops. The infection generally spreads due to lack of access to clean water, sanitation and hygiene, lack of affordable medicine, lack of awareness and knowledge, lack of vaccination and diagnostics, and many more reasons. Adults are mostly prescribed with cefazolin sodium to treat bacterial infection and are expected to hold the major share in the global cefazolin sodium market.
Regional Outlooks
The global cefazolin sodium market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can also be analyzed for particular region or country level as per the requirement.
Global Cefazolin Sodium Market Growth, by Region 2022-2028
The Asia-Pacific Region is Anticipated to Hold the Major Share in the Global Cefazolin Sodium Market
The Asia-Pacific region is anticipated to hold the major share in the global cefazolin sodium market. This is due to the increasing research and development activities in the healthcare sector as well as the presence of the key market players such as CSPC Pharmaceutical Group Ltd., and LKPC Pharmaceutical Co. Ltd. The key ingredients of cefazolin sodium are supplied from emerging countries like China and India, which is also boosting the market growth. Several government initiatives for the development of new drugs in countries like China and India are another factor fuelling the growth of the market in this region. For instance, the government of India had initiated a Soft Loan for Pharma Industrial R&D Projects, which offers 70% of the project cost at a simple interest of 3% on reducing amount.
Market Players Outlook
The major companies serving the global cefazolin sodium market include CSPC Pharmaceutical Group ltd., Dun& Bradstreet, Inc., HISUN USA Ltd., Pfizer Inc., LKPC Pharmaceutical Co. Ltd., and many more. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches for the advancement of the drug, to stay competitive in the market. For instance, in February 2021, Premier Inc. had partnered with Apotex Corp. to supply three major antibiotics to healthcare providers. This was done to secure the immediate and long term supply of antibiotics medication to treat bacterial infections.
The Report Covers
1.Report Summary
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.BY Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.CSPC Pharmaceutical Group Ltd.
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.Dun& Bradstreet, Inc.
3.2.1.Overview
3.2.2.Financial Analysis
3.2.3.SWOT Analysis
3.2.4.Recent Developments
3.3.HISUN USA Ltd.
3.3.1.Overview
3.3.2.Financial Analysis
3.3.3.SWOT Analysis
3.3.4.Recent Developments
3.4.Pfizer Inc.
3.4.1.Overview
3.4.2.Financial Analysis
3.4.3.SWOT Analysis
3.4.4.Recent Developments
3.5.Novartis AG
3.5.1.Overview
3.5.2.Financial Analysis
3.5.3.SWOT Analysis
3.5.4.Recent Developments
3.6.Key Strategy Analysis
3.7.Impact of Covid-19 on Key Players
4.Market Segmentation
4.1.Global Cefazolin Sodium Market by Type
4.1.1. Antimicrobial Drug
4.1.2Cephalosporins
4.1.3.First generation Cephalosporins
4.2.Global Cefazolin sodium Market by End-User
4.2.1.Adults
4.2.2.Children
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1. Acs Dobfar S.p.A
6.2.Fresenius SE & Co. KGaA
6.3.HPGC
6.4.LKPC Pharmaceutical Co. Ltd.
6.5.North China Pharmaceutical Group Ltd.
6.6.Orchid Pharma Ltd.
6.7.Olon S.p.A.
6.8.Qilu Pharmaceutical Co. Ltd.
6.9.Shandong Lukang Pharmaceutical Co. Ltd.
6.10.Souguang Fukang Pharmaceutical Co. Ltd.
1.GLOBAL CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
2.GLOBAL ANTIMICROBIAL DRUG CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
GLOBAL CEPHALOSPORINS CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
4.GLOBAL FIRST GENERATION CEPHALOSPORINS CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
5.GLOBAL CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2021 - 2028 ($ MILLION)
6.GLOBAL ADULTS TREATED CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
7.GLOBAL CHILDREN TREATED CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
8.GLOBAL CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021 - 2028 ($ MILLION)
9.NORTH AMERICAN CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
10.NORTH AMERICAN CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
11.NORTH AMERICAN CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2021 - 2028 ($ MILLION)
12.EUROPEAN CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
13.EUROPEAN CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
14.EUROPEAN CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2021 - 2028 ($ MILLION)
15.ASIA-PACIFIC CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
16.ASIA-PACIFIC CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
17.ASIA-PACIFIC CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2021 - 2028 ($ MILLION)
18.REST OF THE WORLD CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
19.REST OF THE WORLD CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
20.REST OF THE WORLD CEFAZOLIN SODIUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2021 - 2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL CEFAZOLIN SODIUM MARKET, 2021 - 2028($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL CEFAZOLIN SODIUM MARKET BY SEGMENT, 2021 - 2028($ MILLION)
3.RECOVERY OF GLOBAL CEFAZOLIN SODIUM MARKET, 2021-2027 (%)
4.GLOBAL CEFAZOLIN SODIUM MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5.GLOBAL ANTIMICROBIAL DRUG CEFAZOLIN SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
GLOBAL CEPHALOSPORINS CEFAZOLIN SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL FIRST GENERATION CEPHALOSPORINS CEFAZOLIN SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL CEFAZOLIN SODIUM MARKET SHARE BY END-USER, 2021 VS 2028 (%)
9.GLOBAL ADULTS TREATED CEFAZOLIN SODIUM MAREKT SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL CHILDREN TREATED CEFAZOLIN SODIUM MAREKT SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL CEFAZOLIN SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12.US GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
13.CANADA GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
14.UK GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
15.FRANCE GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
16.GERMANY GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
17.ITALY GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
18.SPAIN GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
19.REST OF EUROPE GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
20.INDIA GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
21.CHINA GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
22.JAPAN GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
23.REST OF ASIA-PACIFIC GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)
24.REST OF THE WORLD GLOBAL CEFAZOLIN SODIUM MARKET SIZE, 2021 - 2028($ MILLION)